Conference Coverage

EuroPCR 2018

Paris, France

May 21, 2018

May 25, 2018

News Conference News EuroPCR 2018

Two Sham-Controlled Renal Denervation Studies Offer Hope in Hypertension

Larger clinical trials are in the works, but investigators and others gathered here say the data breathe new life into this once promising field.

News

News Conference News EuroPCR 2018

STEMI Patients With Persistent Ischemia After PCI: A Potential Target for IABP?

Caitlin E. Cox

May 31, 2018

News Conference News EuroPCR 2018

ORBITA Deep Dive Highlights Treatment Choices, Social Media, and Ethics

Michael O'Riordan

May 31, 2018

News Conference News EuroPCR 2018

DCBs for CAD in Certain Patients With Large Vessel De Novo Disease? DEBUT Says Yes

Caitlin E. Cox

May 25, 2018

News Conference News EuroPCR 2018

Real-World Sapien 3 Results Match Trial Experience in Intermediate-Risk Patients

Caitlin E. Cox

May 25, 2018

News Conference News EuroPCR 2018

‘Transient’ STEMI Patients Can Be Immediately Treated or Safely Deferred to Next Day

Michael O'Riordan

May 24, 2018

Slides

Presentation EuroPCR 2018

ORBITA: A Physiology-stratified Analysis of the Impact of FFR and iFR on Efficacy of Coronary Angioplasty in Stable Coronary Artery Disease

Presenter: Rasha Al-Lamee

May 22, 2018

Presentation EuroPCR 2018

FFR-guided PCI versus Medical Therapy to Reduce Cardiac Death or Myocardial Infarction

Presenter: Frederik M. Zimmermann

May 23, 2018

Presentation EuroPCR 2018

Real World Outcomes of TAVR with the SAPIEN-3 Valve in Intermediate Risk Patients: Comparison of Data from the TVT Registry with PARTNER S3 Studies

Presenter: E. Murat Tuzcu

May 25, 2018

Presentation EuroPCR 2018

GISE Registry of Transcatheter Treatment of Mitral Valve Regurgitation (GIOTTO): Epidemiology and Acute Results

Presenter: Francesco Bedogni

May 23, 2018

All Conference Content

Advertisement

EuroPCR 2018

Two Sham-Controlled Renal Denervation Studies Offer Hope in Hypertension

News

STEMI Patients With Persistent Ischemia After PCI: A Potential Target for IABP?

ORBITA Deep Dive Highlights Treatment Choices, Social Media, and Ethics

DCBs for CAD in Certain Patients With Large Vessel De Novo Disease? DEBUT Says Yes

Real-World Sapien 3 Results Match Trial Experience in Intermediate-Risk Patients

‘Transient’ STEMI Patients Can Be Immediately Treated or Safely Deferred to Next Day

Slides

ORBITA: A Physiology-stratified Analysis of the Impact of FFR and iFR on Efficacy of Coronary Angioplasty in Stable Coronary Artery Disease

FFR-guided PCI versus Medical Therapy to Reduce Cardiac Death or Myocardial Infarction

Real World Outcomes of TAVR with the SAPIEN-3 Valve in Intermediate Risk Patients: Comparison of Data from the TVT Registry with PARTNER S3 Studies

GISE Registry of Transcatheter Treatment of Mitral Valve Regurgitation (GIOTTO): Epidemiology and Acute Results

#EuroPCR

Advertisement

All Conference Content

Advertisement

EuroPCR 2018

News

Slides

Advertisement

All Conference Content

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content

EuroPCR 2018